The idea behind pairing them
The two medicines inhibit the same enzyme but move on different clocks. Sildenafil reaches useful levels quickly and fades within the evening; tadalafil takes longer to arrive and stays for up to thirty-six hours. In one tablet, the intended effect is a fast start and a long tail.
Why it is compounded
No manufacturer makes an FDA-approved tablet containing both. When a clinician judges that a patient needs this specific pairing, a state-licensed compounding pharmacy prepares it to that prescription. Compounded medications are not FDA-approved, and FDA does not review them for safety, effectiveness, or quality before marketing.
Same rules, added care
Everything true of each medicine alone remains true together: no nitrates, honest blood-pressure history, and clinician oversight of the dose. Because two actives share one tablet, starting doses are conservative and adjusted based on how you respond.
PDE5 inhibitors work alongside arousal; they do not create it.
Is it right for you?
That is genuinely not answerable by an article. It depends on your health, your medications, and what you want the medicine to fit around. The intake takes a few minutes; an independent licensed clinician takes it from there, and prescribes only what is medically appropriate. See the 30-second film answers for this medication.
How PDE5 inhibitors actually work
Sexual arousal releases nitric oxide in the penis, which raises cyclic GMP. Cyclic GMP relaxes the smooth muscle of the corpus cavernosum, letting blood flow in. An enzyme called phosphodiesterase type 5 breaks cyclic GMP back down, which is how an erection ends. Sildenafil, tadalafil, and vardenafil inhibit that enzyme, so cyclic GMP persists longer and blood flow is easier to achieve and maintain. The critical consequence of this mechanism is that these medications do not create arousal. Without sexual stimulation there is no nitric oxide release, so there is nothing for the drug to prolong. That is why the label instructs use with stimulation, and why daily versus as-needed dosing is a question about timing rather than potency.
Why onset and duration differ between them
The clinical differences between PDE5 inhibitors are pharmacokinetic rather than mechanistic. According to FDA prescribing information, sildenafil reaches peak plasma concentration in roughly an hour and has a half-life of about four hours, which produces a defined window. Tadalafil has a half-life of approximately 17.5 hours, so its effect persists far longer, which is the basis for both as-needed and low-dose daily regimens. A high-fat meal delays sildenafil absorption; tadalafil is less affected by food. Those facts, not marketing, are what make one preferable for a planned occasion and the other for a less scheduled approach. Sildenafil versus tadalafil compares them directly, and a clinician chooses based on your history.
PDE5 inhibitors are contraindicated with nitrates.
The interactions that genuinely matter
The most important contraindication is absolute: PDE5 inhibitors must not be taken with nitrates in any form, including nitroglycerin tablets, sprays, patches, and recreational amyl nitrite poppers. The combination can cause a profound, dangerous drop in blood pressure. Alpha-blockers used for blood pressure or prostate symptoms require care and often dose separation. Significant cardiovascular disease, recent stroke or heart attack, and certain retinal conditions are reasons a clinician may decline. Seek immediate care for an erection lasting more than four hours, or for sudden vision or hearing loss. This is precisely why an evaluation is required rather than optional, and why buying these medications from a site that does not ask for a history is the risk described in red flags when buying online.
Where apomorphine fits, and how it differs
Apomorphine is not a PDE5 inhibitor and does not act on blood flow. It is a dopamine receptor agonist, and it works centrally, in brain pathways involved in the arousal signal itself. That makes it mechanistically complementary rather than redundant: a PDE5 inhibitor addresses the vascular response, apomorphine addresses the upstream signal. Despite the name, it is not an opioid and is not related to morphine pharmacologically. Nausea is the most commonly described effect, which follows from dopaminergic action on the brainstem. Combination compounded preparations that pair the two mechanisms are not FDA-approved, and FDA does not review compounded preparations for safety, effectiveness, or quality before marketing. Apomorphine explained goes further.
Ten minutes now, and a licensed clinician tells you where you actually stand.
Frequently asked questions
Can you take sildenafil and tadalafil together?
There is no FDA-approved product combining them. Combination preparations are compounded, and compounded medications are not FDA-approved. Whether it is appropriate is entirely a clinician's judgement.
Why would a clinician consider a combination?
The two differ in onset and duration, so the intent is to cover a wider window. Intent is not the same as demonstrated benefit.
Is combining them riskier?
PDE5 inhibitors share a side-effect profile and interact dangerously with nitrates. Combining them requires careful clinical review.
Is it FDA-approved?
No. Compounded medications are not FDA-approved, and FDA does not review them for safety, effectiveness or quality before marketing.
Do I still need an evaluation?
Yes. These are prescription medicines and require evaluation by a licensed clinician.
How long does tadalafil last?
According to FDA prescribing information, tadalafil has a half-life of approximately 17.5 hours, which is why its effect persists considerably longer than sildenafil’s. It still requires sexual stimulation to have any effect.
One honest answer beats ten opinions.
Your intake goes to a licensed clinician, not an algorithm.
Rx only. A licensed clinician decides whether treatment is appropriate and may determine that no treatment, or a different treatment, is right for you. Compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness, or quality before marketing. Individual results vary.
Sources
Clinical trials listed below evaluated FDA-approved products at the doses studied. They are cited as published science, not as evidence about any compounded preparation, which is not FDA-approved and has not been evaluated by FDA for safety, effectiveness, or quality.
- FDAFDA: VIAGRA (sildenafil) prescribing information
- FDAFDA: CIALIS (tadalafil) prescribing information
- FDAFDA: Compounding and the FD&C Act
- FDA databaseDrugs@FDA: search approved labeling for sildenafil and tadalafil
Spotted something inaccurate? Report an error – corrections are logged per our editorial standards.
More on Sexual Health
Same medication, different question.
